Omega-3 consumption and sudden unexpected death in schizophrenia: a “fish” a day keeps heart disease away
Always on the lookout for articles from Psychopharmacology, one in particular has attracted a lot of attention because the results are really fascinating. Xu and colleagues addressed a priority issue in clinical research demonstrating that omega-3 fatty acids (O3FAs) have beneficial effects on triglyceride metabolism in patients with both schizophrenia and metabolic syndrome (MetS) that parallel decreased inflammation levels (Xu et al. 2019). Considering the conflicting published data concerning the role of O3FAs in treating MetS (especially elevated triglyceride levels) in people with schizophrenia, we applaud the authors for pursuing this topic. Moreover, this proposal cited above also deserves reflections with respect to sudden unexpected death (SUD) in schizophrenia.
Schizophrenia is a lifelong, chronic, and severely debilitating mental illness that is often diagnosed in late adolescence or early adulthood (Pennington and McCrone 2017). Unfortunately, life expectancy of...
All wrote and reviewed the final version of the article.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Xu F, Fan W, Wang W, Tang W, Yang F, Zhang Y, Cai J, Song L, Zhang C (2019) Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial. Psychopharmacology. https://doi.org/10.1007/s00213-018-5136-9